Chemotherapy News and Research

Latest Chemotherapy News and Research

Researchers can attack cancer by working together, says UNC Charlotte professor

MUC1 is a protein present on the cells that line most organs. It lubricates and protects them. When cells become malignant, the MUC1 protein changes and signals tumor cells to multiply.

27 May 2017

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

Novartis today announced the US Food and Drug Administration approved the expanded use of Zykadia (ceritinib) to include the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive, as detected by an FDA-approved test.

27 May 2017

Aggressive care in final days of life for advanced cancer patients not linked to better outcomes

For patients with advanced cancer, aggressive care -- chemotherapy, mechanical ventilation, acute hospitalizations and intensive care unit admissions -- at the end of life is commonplace.

25 May 2017

Triple combination of ineffective antibiotics provides new weapon to fight against super bacteria

In the fight against super bacteria, University at Buffalo scientists are relying on strength in numbers to win the battle against drug resistance.

25 May 2017

Men appear to have worse chemotherapy-induced cardiomyopathy than women, research shows

Men seem to have worse chemotherapy-induced cardiomyopathy than women despite receiving similar cancer treatments, according to research presented today at EuroCMR 2017.

25 May 2017

Yearlong study creates detailed map of microbial colonization in a newly opened hospital

A 12-month study mapping bacterial diversity within a hospital - with a focus on the flow of microbes between patients, staff and surfaces - should help hospitals worldwide better understand how to encourage beneficial microbial interactions and decrease potentially harmful contact.

24 May 2017

New study offers insight into how to improve chemotherapy strategies for ovarian cancer

Most women diagnosed with ovarian cancer undergo surgery to remove as many of the tumors as possible. However, it is usually impossible to eliminate all of the cancer cells because they have spread throughout the abdomen. Surgery is therefore followed by 18 weeks of chemotherapy.

24 May 2017

Study points to new pharmacologic approach to target chemo-resistant lung cancer

Patients with non-small cell lung cancer (NSCLC) often respond to standard chemotherapy, only to develop drug resistance later, and with fatal consequences.

23 May 2017

FDA grants accelerated approval to cancer treatment based on common biomarker

The U.S. Food and Drug Administration today granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker).

23 May 2017

Cancer drug may help treat food allergies

A cancer drug for patients with certain types of leukemia and lymphoma can also prevent reactions to some of the most common airborne allergies, according to a recent Northwestern Medicine study. The promising data from this pilot study could have greater implications for adults with food allergies.

22 May 2017

Researchers develop simple, flexible technique for early cancer diagnosis

Earlier discovery of cancer and greater precision in the treatment process are the objectives of a new method developed by researchers at Sahlgrenska Academy and Boston University.

22 May 2017

Rush clinical trial offers new immunotherapy combination to patients fighting kidney cancer

Rush University Medical Center is among the first hospitals in the nation, and the only one in Illinois, to provide patients fighting advanced kidney access to a new combination immunotherapy that targets different immune system cells and processes than a widely used therapy that has been proven effective for some patients but had little effect on others.

22 May 2017

Antibody drug conjugate could hold promise in improving treatment for childhood ALL

Researchers at The University of Manchester have discovered that a protein (5T4) found on the surface of cells contributes to chemotherapy resistance in the most common type of childhood leukaemia.

From The University of Manchester 19 May 2017

Paxman to showcase FDA approved scalp cooler for chemotherapy induced alopecia at ASCO

A pioneering scalp cooling treatment that prevents alopecia in breast cancer patients undergoing chemotherapy will be showcased at the American Society of Clinical Oncology (ASCO) for the first time since gaining FDA clearance.

From Paxman 19 May 2017

New clinical trial offers hope for patients with hard-to-treat cancer caused by asbestos

Patients with a hard-to-treat type of cancer are being given new hope in a ground-breaking clinical trial. Researchers at the University of Southampton and the University of Leicester are trialing a drug that could boost the body's immune system to fight off mesothelioma, which can be caused by asbestos.

19 May 2017

Colon cancer patients with healthy lifestyle have longer disease-free survival, study finds

A study of 992 patients with stage III colon cancer found that those who reported a healthy lifestyle during and following adjuvant (post-surgery) treatment had a 42% lower chance of death and a trend for lower chance of cancer recurrence than those who had less healthy lifestyles.

18 May 2017

Chemotherapy News and Research

Latest Chemotherapy News and Research

Researchers can attack cancer by working together, says UNC Charlotte professor

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

Aggressive care in final days of life for advanced cancer patients not linked to better outcomes

Triple combination of ineffective antibiotics provides new weapon to fight against super bacteria

Men appear to have worse chemotherapy-induced cardiomyopathy than women, research shows

Yearlong study creates detailed map of microbial colonization in a newly opened hospital

New study offers insight into how to improve chemotherapy strategies for ovarian cancer

Study points to new pharmacologic approach to target chemo-resistant lung cancer

FDA grants accelerated approval to cancer treatment based on common biomarker

Cancer drug may help treat food allergies

Researchers develop simple, flexible technique for early cancer diagnosis

Rush clinical trial offers new immunotherapy combination to patients fighting kidney cancer

Antibody drug conjugate could hold promise in improving treatment for childhood ALL

Paxman to showcase FDA approved scalp cooler for chemotherapy induced alopecia at ASCO

New clinical trial offers hope for patients with hard-to-treat cancer caused by asbestos

Colon cancer patients with healthy lifestyle have longer disease-free survival, study finds

Targeted therapy appears to be more effective in preventing lung cancer recurrence

Nut consumption reduces chance of colon cancer recurrence and death, study shows

Researchers explore new treatment combination for pediatric patients with Hodgkin lymphoma

Researchers identify DNA repair deficiency in many types of solid tumors

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in